Related Experiment Videos

Low-molecular-weight heparin in treatment of venous thromboembolism. An emerging theme

R D Hull, G F Pineo

International Angiology : a Journal of the International Union of Angiology

|November 20, 1998

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Effect of extended-duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis.

Journal of thrombosis and haemostasis : JTH·2017

Apixaban after hip or knee arthroplasty versus enoxaparin: efficacy and safety in key clinical subgroups.

Journal of thrombosis and haemostasis : JTH·2013

Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials.

The Journal of bone and joint surgery. British volume·2012

Chronic idiopathic thrombocytogenic purpura.

Canadian family physician Medecin de famille canadien·2011

Individual patient data meta-analysis of enoxaparin vs. unfractionated heparin for venous thromboembolism prevention in medical patients.

Journal of thrombosis and haemostasis : JTH·2011

Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review.

Annals of internal medicine·2001

See all related articles